Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- −13 vs. Q1 2025
- Shares held
- 123.6M
- −1.34M (−1.1%) vs. Q1 2025
- Total value
- $1.62B
- −$173.8M (−9.7%) vs. Q1 2025
- New holders
- 19
- 45 more added
- Sold out
- 32
- 34 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,793,471 | $23.6M | 0.00% | −1,143,996−38.9% | Reduced |
| Cormorant Asset Management, LP | 2,086,600 | $27.4M | 2.04% | −175,000−7.7% | Reduced |
| Franklin Resources Inc | 2,543,539 | $33.4M | 0.01% | +1,540+0.1% | Added |
| Point72 Asset Management, L.P. | 2,591,596 | $34.1M | 0.08% | +305,163+13.3% | Added |
| TCG Crossover Management, LLC | 2,890,816 | $38.0M | 4.34% | 00.0% | Unchanged |
| Commodore Capital LP | 3,298,289 | $43.3M | 3.06% | +930,711+39.3% | Added |
| Siren, L.L.C. | 3,460,029 | $45.5M | 2.35% | +500,000+16.9% | Added |
| FMR LLC | 3,826,194 | $50.3M | 0.00% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 4,293,411 | $56.4M | 7.31% | −580,713−11.9% | Reduced |
| Farallon Capital Management, L.L.C. | 4,529,318 | $59.5M | 0.27% | +195,000+4.5% | Added |
| Avoro Capital Advisors LLC | 5,000,000 | $65.7M | 1.15% | +950,000+23.5% | Added |
| Price T Rowe Associates Inc | 5,907,992 | $77.6M | 0.01% | +565,648+10.6% | Added |
| Janus Henderson Group PLC | 6,532,768 | $85.8M | 0.04% | +610,282+10.3% | Added |
| Adage Capital Partners GP, L.L.C. | 8,403,000 | $110.4M | 0.19% | +1,449,000+20.8% | Added |
| General Atlantic LLC | 9,681,818 | $127.2M | 3.51% | 00.0% | Unchanged |
| Index Venture Life Associates VI Ltd | 9,961,789 | $130.9M | 100.00% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $262.3M | 61.40% | 00.0% | Unchanged |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −2,255,679−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −1,227,178−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −899,505−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −706,331−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −529,000−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −446,196−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −418,127−100.0% | Sold out |
| Wildcat Capital Management, LLC | 0 | $0 | 0.00% | −281,859−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −164,048−100.0% | Sold out |
| Oakmont Corp | 0 | $0 | 0.00% | −92,064−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −82,199−100.0% | Sold out |
| Regents of the University of California | 0 | $0 | 0.00% | −81,884−100.0% | Sold out |
| Ellsworth Advisors, LLC | 0 | $0 | 0.00% | −48,872−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −42,437−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −40,868−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −37,720−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −35,226−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −32,754−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −28,381−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −21,917−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −16,269−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −15,785−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −14,888−100.0% | Sold out |
| Harbour Capital Advisors, LLC | 0 | $0 | 0.00% | −16,375−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −14,617−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −11,111−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,257−100.0% | Sold out |
| Osterweis Capital Management Inc | 0 | $0 | 0.00% | – | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −3,215−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Caldwell Sutter Capital, Inc. | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −31−100.0% | Sold out |